文献速递肿瘤 PET/CT骨显像与常规 SPECT

明确99mTc-MIBI SPECT/CT在增强实性肾肿块表征中相对于常规横断面成像的附加价值

Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.
PubMed 文献 · Clin Nucl Med · 2017-01-01

本前瞻性临床试验纳入48例临床T1期实性肾肿块患者,术前行99mTc-MIBI SPECT/CT,回顾性调取术前8周内常规CT和MRI,由2名盲法读者按5分法分别于查看99mTc-MIBI摄取比值前后记录诊断信心,以手术病理为参考标准。结果显示,附加99mTc-MIBI SPECT/CT使14/48个病灶(29.2%)的诊断信心提高,ROC曲线下面积由常规成像的0.60升至0.85(差值P=0.03)。

要点

  • 99mTc-MIBI SPECT/CT使29.2%(14/48)实性肾肿块的诊断信心提高。
  • 9个病灶的诊断信心由恶性转向良性,其中7个病理为良性,2个为嫌色细胞肾细胞癌。
  • 5个病灶的诊断信心转向恶性,均经手术病理证实为肾细胞癌。

核心结论

  • 术前99mTc-MIBI SPECT/CT可增强常规成像的性能,改善良性组织学的表征并降低误分类的可能性。

研究设计与样本

  • 研究为经机构审查委员会批准的前瞻性临床试验的一部分,纳入48例临床T1期实性肾肿块患者,均在部分或根治性肾切除术前接受99mTc-MIBI SPECT/CT。
  • 常规CT和MRI于99mTc-MIBI检查前约8周内进行,并被回顾性调取。
  • 由2名盲法读者按5分法(1=肯定良性,5=肯定恶性)在查看99mTc-MIBI摄取比值前后分别记录每个病灶的诊断信心,以手术病理为参考标准。

主要发现

  • 附加查看99mTc-MIBI SPECT/CT摄取比值使14/48个病灶(29.2%)的实性肾肿块鉴别诊断信心提高。
  • 9个病灶在附加99mTc-MIBI后初始恶性诊断信心转向良性诊断,术后病理证实其中7个为良性组织学(嗜酸细胞瘤/杂交嗜酸细胞-嫌色细胞肿瘤),2个为嫌色细胞肾细胞癌(呈惰性行为)。
  • 5个病灶在附加99mTc-MIBI后诊断信心转向恶性,均经手术病理证实为肾细胞癌。
  • 常规成像单独应用的受试者工作特征曲线下面积为0.60,查看99mTc-MIBI后为0.85(差值P=0.03)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study investigates whether the addition of preoperative Tc-MIBI SPECT/CT can increase the degree of diagnostic confidence in the differentiation of benign from malignant enhancing renal masses. PATIENTS AND METHODS: Patients were recruited as part of an institutional review board-approved prospective clinical trial. Forty-eight patients with clinical stage T1 solid renal masses who underwent a Tc-MIBI SPECT/CT before partial or radical nephrectomy were evaluated. Conventional CT and MRI, which were approximately performed within 8 weeks before Tc-MIBI, were retrospectively retrieved. Based on a 5-point scale (1 = definitely benign, 5 = definitely malignant), 2 blinded readers recorded their degree of confidence for each lesion using conventional imaging before and after reviewing the Tc-MIBI uptake ratios. Surgical pathology was considered as the reference standard. RESULTS: Additional review of Tc-MIBI SPECT/CT uptake ratios increased diagnostic confidence in the differentiation of solid renal masses in 14/48 lesions (29.2%). In 9 lesions, the addition of Tc-MIBI changed the initial confidence levels of malignancy toward benign diagnosis. Postsurgical pathology confirmed the diagnosis of benign histology (oncocytoma/hybrid oncocytic-chromophobe tumors) in 7 and chromophobe renal cell carcinoma (behave as indolent) in 2 of these lesions. Tc-MIBI increased the confidence level toward malignancy in 5 cases; all were confirmed as RCC on surgical pathology. The area under the receiver operative characteristic curve was 0.60 for conventional imaging alone and 0.85 after reviewing Tc-MIBI (P for difference = 0.03). CONCLUSIONS: Preoperative Tc-MIBI SPECT/CT enhances the performance of conventional imaging, improving the characterization of benign histologies and lowering the possibility of misclassification.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sheikhbahaei S, Jones CS, Porter KK, et al. Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses. Clin Nucl Med. 2017. PMID: 28114223. doi:10.1097/RLU.0000000000001534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。